Hepatitis B complicated focal segmental glomerulosclerosis

Journal of Nephrology

Volumn 18, Issue 4, 2005, Pages 433-435

  Sakallioglu, Onur ^a   Gok, Faysal ^a   Kalman, Suleyman ^a   Kurekci, Ahmet Emin ^a   Gunhan, Omer ^a   Gokcay, Erdal ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Carticosteroid; Chronic hepatitis B; Focal segmental glomerulosclerosis; Interferon ; Lamivudine

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; METHYLPREDNISOLONE; PREDNISONE;

ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; DRUG MEGADOSE; FOCAL GLOMERULOSCLEROSIS; HEPATITIS B; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; MALE; MONOTHERAPY; NEPHROTIC SYNDROME; REMISSION; SCHOOL CHILD; TREATMENT OUTCOME; URINALYSIS; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BIOPSY; CHILD; DNA, VIRAL; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GLUCOCORTICOIDS; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; LAMIVUDINE; MALE; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 28244454804     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. di Belgiojoso GB, Ferrario F, Landriani N. Virus-related glomerular disease: histologic and clinical aspects. J Nephrol 2002; 15: 469-79.
2. Combes B, Shorey J, Barrera A, Stastny P, Eigenbrodt EH, Hull AR, Carter NW. Glomerulonephritis with deposition of Australian antigen-antibody complexes in glomerular basement membrane. Lancet 1971; 2: 234-7.
3. Zhang YE, Guo MY, Ying YY. Further study on the immunopathology of hepatitis B virus associated glomerulonephritis. Zhonghua Nei Ke Za Zhi 1990; 29: 526-74.
4. Bruce M, Lieberman E, Mendoza SA. Steroid resistant nephrotic focal segmental glomerulosclerosis: a treatable disease. Pediatr Nephrol 1996; 10: 772-8.
5. Mallick N. Secondary FSGS not due to HIV. Nephrol Dial Transplant 2003; 18 (suppl 6): S64-7.
6. Lai KN, Tam JS, Lin HJ, Lai FM. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron 1990; 54: 12-7.
7. Lai KN, Li PK, Lui SF, Au TC, Tam JS, Tong KL, Lai FM. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991; 324: 1457-63.
8. Wyszynska T, Jung H, Madalinski K, Morzycka M. Hepatitis B mediated glomerulonephritis in children. Int J Pediatr Nephrol 1984; 5: 147-58.
9. Oner A, Tinaztepe K, Demircin G. Hepatitis-B-associated glomerulonephritis in children. Turk J Pediatr 1997; 39: 239-46.
10. Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with HBe-Ag-positive chronic hepatitis B; A meta-analysis. Ann Intern Med 1993; 119: 312-23.
11. Iwata Y, Wada T, Yoshimoto K, Sakai N, Shimizu M, Furuichi K, Hisada Y, Kobayashi K, Yokoyama H. Effect of interferon therapy on hepatitis B virus related membranous nephropathy associated with focal segmental glomerulosclerosis. Nippon Jinzo Gakkai Shi 2001; 43: 76-81.
12. Dienstag JL, Schiff ER, Mitchell M. Extended lamivudine retreatment for chronic hepatitis B. Hepatology 1996; 24: 188A.